[{"id":"cb11cd54-0bac-4f20-bf14-95c5e18524bf","acronym":"","url":"https://clinicaltrials.gov/study/NCT04187703","created_at":"2022-04-24T09:01:41.679Z","updated_at":"2024-07-02T16:35:15.464Z","phase":"Phase 1","brief_title":"5-Azacitidine and Decitabine Epigenetic Therapy for Myeloid Malignancies","source_id_and_acronym":"NCT04187703","lead_sponsor":"Benjamin Tomlinson","biomarkers":" ABL1 • BCR • CD14 • DCK • DNMT1 • ITGAM • NT5C","pipe":" | ","alterations":" Chr del(5q)","tags":["ABL1 • BCR • CD14 • DCK • DNMT1 • ITGAM • NT5C"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Chr del(5q)"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e azacitidine • decitabine"],"overall_status":"Recruiting","enrollment":" Enrollment 20","initiation":"Initiation: 11/16/2020","start_date":" 11/16/2020","primary_txt":" Primary completion: 12/01/2024","primary_completion_date":" 12/01/2024","study_txt":" Completion: 12/01/2025","study_completion_date":" 12/01/2025","last_update_posted":"2024-03-11"},{"id":"2f5faace-17d7-4cff-b721-8014409cdd5f","acronym":"","url":"https://clinicaltrials.gov/study/NCT05811546","created_at":"2023-04-13T14:03:16.109Z","updated_at":"2024-07-02T16:35:50.662Z","phase":"","brief_title":"Immunohistochemical Evaluation of DNA Methylation and Histone Modification in H. Pylori Associated Gastric Carcinoma","source_id_and_acronym":"NCT05811546","lead_sponsor":"Assiut University","biomarkers":" EZH2 • DNMT1","pipe":"","alterations":" ","tags":["EZH2 • DNMT1"],"overall_status":"Recruiting","enrollment":" Enrollment 68","initiation":"Initiation: 05/01/2022","start_date":" 05/01/2022","primary_txt":" Primary completion: 12/31/2024","primary_completion_date":" 12/31/2024","study_txt":" Completion: 12/31/2024","study_completion_date":" 12/31/2024","last_update_posted":"2023-04-13"},{"id":"a25a7657-8064-40e7-806c-f6d355167a9b","acronym":"","url":"https://clinicaltrials.gov/study/NCT05042531","created_at":"2021-09-13T14:55:55.634Z","updated_at":"2024-07-02T16:36:11.575Z","phase":"","brief_title":"Clinical Research for Azacitidine Combined With Low-dose Dasatinib in Maintenance Therapy of Acute Myeloid Leukemia","source_id_and_acronym":"NCT05042531","lead_sponsor":"LanZhou University","biomarkers":" TP53 • CDH1 • CASP3 • DNMT1 • CASP8 • DNMT3B • CDKN1A","pipe":"","alterations":" ","tags":["TP53 • CDH1 • CASP3 • DNMT1 • CASP8 • DNMT3B • CDKN1A"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e dasatinib • azacitidine"],"overall_status":"Recruiting","enrollment":" Enrollment 30","initiation":"Initiation: 11/13/2021","start_date":" 11/13/2021","primary_txt":" Primary completion: 09/01/2023","primary_completion_date":" 09/01/2023","study_txt":" Completion: 12/15/2023","study_completion_date":" 12/15/2023","last_update_posted":"2022-04-25"},{"id":"96c2db85-8b70-4dcd-9ee7-0289eacce37f","acronym":"","url":"https://clinicaltrials.gov/study/NCT01912820","created_at":"2021-01-18T08:37:27.785Z","updated_at":"2024-07-02T16:36:28.720Z","phase":"Phase 1","brief_title":"Effect of Quercetin on Green Tea Polyphenol Uptake in Prostate Tissue From Patients With Prostate Cancer Undergoing Surgery","source_id_and_acronym":"NCT01912820","lead_sponsor":"Jonsson Comprehensive Cancer Center","biomarkers":" DNMT1 • COMT","pipe":"","alterations":" ","tags":["DNMT1 • COMT"],"overall_status":"Completed","enrollment":" Enrollment 32","initiation":"Initiation: 01/01/2014","start_date":" 01/01/2014","primary_txt":" Primary completion: 01/31/2016","primary_completion_date":" 01/31/2016","study_txt":" Completion: 06/10/2021","study_completion_date":" 06/10/2021","last_update_posted":"2021-06-23"},{"id":"7c0bee29-df1b-4e9b-b2b5-18c7da2b5b1d","acronym":"","url":"https://clinicaltrials.gov/study/NCT01478685","created_at":"2021-01-18T06:10:19.405Z","updated_at":"2024-07-02T16:36:53.840Z","phase":"Phase 1","brief_title":"A Phase 1 Study of CC-486 as a Single Agent and in Combination With Carboplatin or ABI-007 in Subjects With Relapsed or Refractory Solid Tumors","source_id_and_acronym":"NCT01478685","lead_sponsor":"Celgene","biomarkers":" DNMT1","pipe":"","alterations":" ","tags":["DNMT1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e carboplatin • albumin-bound paclitaxel • Onureg (azacitidine oral)"],"overall_status":"Completed","enrollment":" Enrollment 169","initiation":"Initiation: 11/29/2011","start_date":" 11/29/2011","primary_txt":" Primary completion: 11/17/2015","primary_completion_date":" 11/17/2015","study_txt":" Completion: 11/17/2015","study_completion_date":" 11/17/2015","last_update_posted":"2019-11-12"},{"id":"5d21a531-89ef-4611-bf99-7667d305b007","acronym":"","url":"https://clinicaltrials.gov/study/NCT02847000","created_at":"2021-01-18T13:58:34.108Z","updated_at":"2024-07-02T16:37:04.074Z","phase":"Phase 1","brief_title":"p53/p16-Independent Epigenetic Therapy With Oral Decitabine/Tetrahydrouridine for Pancreatic Cancer","source_id_and_acronym":"NCT02847000","lead_sponsor":"Yogen Saunthararajah","biomarkers":" DNMT1","pipe":"","alterations":" ","tags":["DNMT1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e decitabine"],"overall_status":"Completed","enrollment":" Enrollment 13","initiation":"Initiation: 12/20/2016","start_date":" 12/20/2016","primary_txt":" Primary completion: 10/25/2017","primary_completion_date":" 10/25/2017","study_txt":" Completion: 10/30/2017","study_completion_date":" 10/30/2017","last_update_posted":"2019-01-09"}]